FDA Inspection 1100263 — BioPharma Services USA Inc.
The FDA completed an inspection of BioPharma Services USA Inc. on July 26, 2019 in Columbia, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 26, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Columbia, MO (United States)
Additional Details
Clinical BA/BE